- •Hematuria II: causes and investigation
- •Hematospermia
- •Lower urinary tract symptoms (LUTS)
- •Nocturia and nocturnal polyuria
- •Flank pain
- •Urinary incontinence in adults
- •Genital symptoms
- •Abdominal examination in urological disease
- •Digital rectal examination (DRE)
- •Lumps in the groin
- •Lumps in the scrotum
- •2 Urological investigations
- •Urine examination
- •Urine cytology
- •Radiological imaging of the urinary tract
- •Uses of plain abdominal radiography (KUB X-ray—kidneys, ureters, bladder)
- •Intravenous pyelography (IVP)
- •Other urological contrast studies
- •Computed tomography (CT) and magnetic resonance imaging (MRI)
- •Radioisotope imaging
- •Post-void residual urine volume measurement
- •3 Bladder outlet obstruction
- •Regulation of prostate growth and development of benign prostatic hyperplasia (BPH)
- •Pathophysiology and causes of bladder outlet obstruction (BOO) and BPH
- •Benign prostatic obstruction (BPO): symptoms and signs
- •Diagnostic tests in men with LUTS thought to be due to BPH
- •Why do men seek treatment for their symptoms?
- •Watchful waiting for uncomplicated BPH
- •Medical management of BPH: combination therapy
- •Medical management of BPH: alternative drug therapy
- •Minimally invasive management of BPH: surgical alternatives to TURP
- •Invasive surgical alternatives to TURP
- •TURP and open prostatectomy
- •Indications for and technique of urethral catheterization
- •Indications for and technique of suprapubic catheterization
- •Management of nocturia and nocturnal polyuria
- •High-pressure chronic retention (HPCR)
- •Bladder outlet obstruction and retention in women
- •Urethral stricture disease
- •4 Incontinence
- •Causes and pathophysiology
- •Evaluation
- •Treatment of sphincter weakness incontinence: injection therapy
- •Treatment of sphincter weakness incontinence: retropubic suspension
- •Treatment of sphincter weakness incontinence: pubovaginal slings
- •Overactive bladder: conventional treatment
- •Overactive bladder: options for failed conventional therapy
- •“Mixed” incontinence
- •Post-prostatectomy incontinence
- •Incontinence in the elderly patient
- •Urinary tract infection: microbiology
- •Lower urinary tract infection
- •Recurrent urinary tract infection
- •Urinary tract infection: treatment
- •Acute pyelonephritis
- •Pyonephrosis and perinephric abscess
- •Other forms of pyelonephritis
- •Chronic pyelonephritis
- •Septicemia and urosepsis
- •Fournier gangrene
- •Epididymitis and orchitis
- •Periurethral abscess
- •Prostatitis: presentation, evaluation, and treatment
- •Other prostate infections
- •Interstitial cystitis
- •Tuberculosis
- •Parasitic infections
- •HIV in urological surgery
- •6 Urological neoplasia
- •Pathology and molecular biology
- •Prostate cancer: epidemiology and etiology
- •Prostate cancer: incidence, prevalence, and mortality
- •Prostate cancer pathology: premalignant lesions
- •Counseling before prostate cancer screening
- •Prostate cancer: clinical presentation
- •PSA and prostate cancer
- •PSA derivatives: free-to-total ratio, density, and velocity
- •Prostate cancer: transrectal ultrasonography and biopsies
- •Prostate cancer staging
- •Prostate cancer grading
- •General principles of management of localized prostate cancer
- •Management of localized prostate cancer: watchful waiting and active surveillance
- •Management of localized prostate cancer: radical prostatectomy
- •Postoperative course after radical prostatectomy
- •Prostate cancer control with radical prostatectomy
- •Management of localized prostate cancer: radical external beam radiotherapy (EBRT)
- •Management of localized prostate cancer: brachytherapy (BT)
- •Management of localized and radiorecurrent prostate cancer: cryotherapy and HIFU
- •Management of locally advanced nonmetastatic prostate cancer (T3–4 N0M0)
- •Management of advanced prostate cancer: hormone therapy I
- •Management of advanced prostate cancer: hormone therapy II
- •Management of advanced prostate cancer: hormone therapy III
- •Management of advanced prostate cancer: androgen-independent/ castration-resistant disease
- •Palliative management of prostate cancer
- •Prostate cancer: prevention; complementary and alternative therapies
- •Bladder cancer: epidemiology and etiology
- •Bladder cancer: pathology and staging
- •Bladder cancer: presentation
- •Bladder cancer: diagnosis and staging
- •Muscle-invasive bladder cancer: surgical management of localized (pT2/3a) disease
- •Muscle-invasive bladder cancer: radical and palliative radiotherapy
- •Muscle-invasive bladder cancer: management of locally advanced and metastatic disease
- •Bladder cancer: urinary diversion after cystectomy
- •Transitional cell carcinoma (UC) of the renal pelvis and ureter
- •Radiological assessment of renal masses
- •Benign renal masses
- •Renal cell carcinoma: epidemiology and etiology
- •Renal cell carcinoma: pathology, staging, and prognosis
- •Renal cell carcinoma: presentation and investigations
- •Renal cell carcinoma: active surveillance
- •Renal cell carcinoma: surgical treatment I
- •Renal cell carcinoma: surgical treatment II
- •Renal cell carcinoma: management of metastatic disease
- •Testicular cancer: epidemiology and etiology
- •Testicular cancer: clinical presentation
- •Testicular cancer: serum markers
- •Testicular cancer: pathology and staging
- •Testicular cancer: prognostic staging system for metastatic germ cell cancer
- •Testicular cancer: management of non-seminomatous germ cell tumors (NSGCT)
- •Testicular cancer: management of seminoma, IGCN, and lymphoma
- •Penile neoplasia: benign, viral-related, and premalignant lesions
- •Penile cancer: epidemiology, risk factors, and pathology
- •Squamous cell carcinoma of the penis: clinical management
- •Carcinoma of the scrotum
- •Tumors of the testicular adnexa
- •Urethral cancer
- •Wilms tumor and neuroblastoma
- •7 Miscellaneous urological diseases of the kidney
- •Cystic renal disease: simple cysts
- •Cystic renal disease: calyceal diverticulum
- •Cystic renal disease: medullary sponge kidney (MSK)
- •Acquired renal cystic disease (ARCD)
- •Autosomal dominant (adult) polycystic kidney disease (ADPKD)
- •Ureteropelvic junction (UPJ) obstruction in adults
- •Anomalies of renal ascent and fusion: horseshoe kidney, pelvic kidney, malrotation
- •Renal duplications
- •8 Stone disease
- •Kidney stones: epidemiology
- •Kidney stones: types and predisposing factors
- •Kidney stones: mechanisms of formation
- •Evaluation of the stone former
- •Kidney stones: presentation and diagnosis
- •Kidney stone treatment options: watchful waiting
- •Stone fragmentation techniques: extracorporeal lithotripsy (ESWL)
- •Intracorporeal techniques of stone fragmentation (fragmentation within the body)
- •Kidney stone treatment: percutaneous nephrolithotomy (PCNL)
- •Kidney stones: open stone surgery
- •Kidney stones: medical therapy (dissolution therapy)
- •Ureteric stones: presentation
- •Ureteric stones: diagnostic radiological imaging
- •Ureteric stones: acute management
- •Ureteric stones: indications for intervention to relieve obstruction and/or remove the stone
- •Ureteric stone treatment
- •Treatment options for ureteric stones
- •Prevention of calcium oxalate stone formation
- •Bladder stones
- •Management of ureteric stones in pregnancy
- •Hydronephrosis
- •Management of ureteric strictures (other than UPJ obstruction)
- •Pathophysiology of urinary tract obstruction
- •Ureter innervation
- •10 Trauma to the urinary tract and other urological emergencies
- •Renal trauma: clinical and radiological assessment
- •Renal trauma: treatment
- •Ureteral injuries: mechanisms and diagnosis
- •Ureteral injuries: management
- •Bladder and urethral injuries associated with pelvic fractures
- •Bladder injuries
- •Posterior urethral injuries in males and urethral injuries in females
- •Anterior urethral injuries
- •Testicular injuries
- •Penile injuries
- •Torsion of the testis and testicular appendages
- •Paraphimosis
- •Malignant ureteral obstruction
- •Spinal cord and cauda equina compression
- •11 Infertility
- •Male reproductive physiology
- •Etiology and evaluation of male infertility
- •Lab investigation of male infertility
- •Oligospermia and azoospermia
- •Varicocele
- •Treatment options for male factor infertility
- •12 Disorders of erectile function, ejaculation, and seminal vesicles
- •Physiology of erection and ejaculation
- •Impotence: evaluation
- •Impotence: treatment
- •Retrograde ejaculation
- •Peyronie’s disease
- •Priapism
- •13 Neuropathic bladder
- •Innervation of the lower urinary tract (LUT)
- •Physiology of urine storage and micturition
- •Bladder and sphincter behavior in the patient with neurological disease
- •The neuropathic lower urinary tract: clinical consequences of storage and emptying problems
- •Bladder management techniques for the neuropathic patient
- •Catheters and sheaths and the neuropathic patient
- •Management of incontinence in the neuropathic patient
- •Management of recurrent urinary tract infections (UTIs) in the neuropathic patient
- •Management of hydronephrosis in the neuropathic patient
- •Bladder dysfunction in multiple sclerosis, in Parkinson disease, after stroke, and in other neurological disease
- •Neuromodulation in lower urinary tract dysfunction
- •14 Urological problems in pregnancy
- •Physiological and anatomical changes in the urinary tract
- •Urinary tract infection (UTI)
- •Hydronephrosis
- •15 Pediatric urology
- •Embryology: urinary tract
- •Undescended testes
- •Urinary tract infection (UTI)
- •Ectopic ureter
- •Ureterocele
- •Ureteropelvic junction (UPJ) obstruction
- •Hypospadias
- •Normal sexual differentiation
- •Abnormal sexual differentiation
- •Cystic kidney disease
- •Exstrophy
- •Epispadias
- •Posterior urethral valves
- •Non-neurogenic voiding dysfunction
- •Nocturnal enuresis
- •16 Urological surgery and equipment
- •Preparation of the patient for urological surgery
- •Antibiotic prophylaxis in urological surgery
- •Complications of surgery in general: DVT and PE
- •Fluid balance and management of shock in the surgical patient
- •Patient safety in the operating room
- •Transurethral resection (TUR) syndrome
- •Catheters and drains in urological surgery
- •Guide wires
- •JJ stents
- •Lasers in urological surgery
- •Diathermy
- •Sterilization of urological equipment
- •Telescopes and light sources in urological endoscopy
- •Consent: general principles
- •Cystoscopy
- •Transurethral resection of the prostate (TURP)
- •Transurethral resection of bladder tumor (TURBT)
- •Optical urethrotomy
- •Circumcision
- •Hydrocele and epididymal cyst removal
- •Nesbit procedure
- •Vasectomy and vasovasostomy
- •Orchiectomy
- •Urological incisions
- •JJ stent insertion
- •Nephrectomy and nephroureterectomy
- •Radical prostatectomy
- •Radical cystectomy
- •Ileal conduit
- •Percutaneous nephrolithotomy (PCNL)
- •Ureteroscopes and ureteroscopy
- •Pyeloplasty
- •Laparoscopic surgery
- •Endoscopic cystolitholapaxy and (open) cystolithotomy
- •Scrotal exploration for torsion and orchiopexy
- •17 Basic science of relevance to urological practice
- •Physiology of bladder and urethra
- •Renal anatomy: renal blood flow and renal function
- •Renal physiology: regulation of water balance
- •Renal physiology: regulation of sodium and potassium excretion
- •Renal physiology: acid–base balance
- •18 Urological eponyms
- •Index
432 CHAPTER 10 Trauma to the urinary tract
Ureteral injuries: mechanisms and diagnosis
Types, causes, and mechanisms
•External: nearly always due to penetrating trauma (knife or gunshot wounds); only rarely due to blunt trauma
•Iatrogenic: during pelvic or abdominal surgery (e.g., hysterectomy, colectomy, appendectomy, AAA repair; repeated or traumatic ureteroscopy). The ureter may be divided, ligated, or angulated by a suture or damaged by diathermy.
External injury: diagnosis
Suspicion for possible ureteral injury is based on wound location or the above clinical scenarios. Hematuria may be absent in 30% of cases.
Imaging studies
In stable patients, contrasted CT with delayed cuts (10–20 minutes) is superior to IVP for clearly determining the presence of a ureteric injury (Fig. 10.6). If doubt remains regarding the integrity of the ureters, retrograde pyelography should be done.
Iatrogenic injury: diagnosis
The injury may be suspected at the time of surgery, but injury may not become apparent until some days or weeks postoperatively.
Intraoperative diagnosis
Direct inspection of the ureter
IVP is notoriously inaccurate for detecting ureteral injuries. Direct intraoperative inspection of the ureter is the best way to detect injury of the ureter. IV injection of methylene blue or indigo carmine may reveal a laceration. Direct injection into the ureter, either retrograde or antegrade, may also reveal extravasation from a laceration.
Ureteral contusion
Discoloration of the ureter observed during laparotomy suggests ischemic injury related to a blast effect after an abdominal gunshot wound. This may lead to a delayed slough and leak if not repaired and/or stented primarily.
Postoperative diagnosis
The diagnosis is usually apparent in the first few days following surgery (see Box 10.3), but it may be delayed by weeks, months, or years (presentation is flank pain; post-hysterectomy incontinence—continuous leak of urine suggests a ureterovaginal fistula).
Investigation
Ultrasonography may demonstrate hydronephrosis, but hydronephrosis may be absent when urine is leaking from a transected ureter into the retroperitoneum or peritoneal cavity.
IVP may show an obstructed ureter or possibly a contrast leak from the site of injury, but CT is more accurate and is thus preferred. Retrograde pyelogram is an accurate method of delineating the site of injury, but is best used in conjunction with attempted stent placement.
URETERAL INJURIES: MECHANISMS AND DIAGNOSIS 433
Figure 10.6 CT of patient with right ureteral injury after stab wound.
Box 10.3 Symptoms and signs of ureteral injury
These may include the following:
•Ileus (due to urine within the peritoneal cavity)
•Prolonged postoperative fever or overt urinary sepsis
•Drainage of fluid from drains, abdominal wound, or vagina. Send aliquot for creatinine estimation. Creatinine level higher than that of serum = urine (creatinine level will be at least 300 µmol/L
[4.0 mg/dL]).
•Flank pain if the ureter has been ligated
•Abdominal mass, representing a urinoma
•Vague abdominal pain
•The pathology report on the organ that has been removed may note presence of segment of ureter.
434 CHAPTER 10 Trauma to the urinary tract
Ureteral injuries: management
When to repair the ureteral injury
In general, the best time to repair the ureter is as soon as the injury has been diagnosed (if intraoperatively), or if the diagnosis is made within the first week after injury. If the diagnosis is made between days 7 and 14 after ureteric injury, caution is advised, since edema and inflammation at the site of repair often occur.
Percutaneous nephrostomy should be placed, the infection drained percutaneously, intravenous antibiotics given, and ureteric repair delayed until the patient is stable and afebrile.
Delay definitive ureteral repair when
•The patient is unable to tolerate a prolonged procedure under general anesthesia—(consider damage control: divert urine by placing a 90 cm single J stent through the defect into the kidney, suture into place, and bring out to abdominal wall in anticipation of later repair).
•There is evidence of active infection at the site of proposed ureteral repair (infected urinoma).
•Diagnosis is made more than 14 days after injury.
Definitive treatment of ureteral injuries
The options depend on the following:
•Whether the injury is recognized immediately
•The nature and level of injury
•Other associated problems
The options are as follows (see also Box 10.4):
•JJ stenting for 3–6 weeks (e.g., ligature injury from absorbable suture—may cut suture if recognized intraoperatively). Stent
placement is also indicated for cases of ureterovaginal fistula.
• Primary closure of partial transection of the ureter and stent placement
•Direct spatulated anastomosis (primary ureteroureterostomy)—if the defect between the ends of the ureter is short (<2 cm) and a tensionfree anastomosis is possible (usually performed for upper ureteral injuries in a setting of immediate laparotomy after a gunshot wound)
•Reimplantation of the ureter into the bladder (ureteroneocystostomy) either directly (for short traumatic lower ureteral injuries) or with psoas hitch and/or a Boari bladder flap (for longer injuries or those associated with extensive fibrosis; Figs. 10.7 and 10.8) may reach up to L4–5 level.
•Transureteroureterostomy (Fig. 10.9) is only used in a setting of advanced pelvic fibrosis, and is contraindicated if there is history of stone disease or pelvic malignancy (best used in delayed setting).
•Replacement of the ureter with ileum is used when the segment of damaged ureter is very long. It is used rarely, only if the urinary tract cannot be used (e.g., Boari bladder flap), in a delayed setting.
•Autotransplantation of the kidney into the pelvis is used when the segment of damaged ureter is very long.
•Permanent cutaneous ureterostomy is used when the patient’s life expectancy is limited.
URETERAL INJURIES: MANAGEMENT 435
Nephrectomy is traditionally advocated for ureteral injury during vascular graft procedures (e.g., aortobifemoral graft for AAA), but the current trend is toward repair and renal preservation, reserving nephrectomy only when urine leak develops postoperatively.1
Nephrectomy is best used when ureteral injury is high and extensive, and the patient is not a candidate for ileal ureter or Boari flap reconstruction (e.g., hostile abdomen, older or debilitated patient).
Box 10.4 General principles of ureteric repair
•Optical magnification via 2.5x loupes is suggested.
•The ends of the ureter should be mobilized and débrided judiciously.
•The anastomosis must be tension free.
•For complete transection, the ends of the ureter should be spatulated, to allow a wide anastomosis to be done.
•A stent should be placed across the repair.
•Mucosa-to-mucosa anastomosis should be done, to achieve a watertight closure.
•Use fine sutures (4/0 or 5–0 absorbable suture material on RB-1 needle).
•A drain should be placed near the site of anastomosis.
•Repair should be covered with the peritoneal flap and/or retroperitoneal fat to exclude the site from the abdominal cavity.
1 McAninch JW (2002). In Walsh PC, Retik AB, Vaughan ED, Wein AJ (Eds.) Campbell’s Urology, 8th edition. Philadelphia: W.B. Saunders, pp. 3703–3714.
436 CHAPTER 10 Trauma to the urinary tract
Figure 10.7 A psoas hitch. This figure was published in Walsh PC, et al. Campbell’s Urology, 8th edition, pp. 3703–3714. Copyright Elsevier 2002.
URETERAL INJURIES: MANAGEMENT 437
Damaged ureter
Incision for flap
A
B
C
Figure 10.8 A Boari flap. This figure was published in Walsh PC, et al. Campbell’s Urology, 8th edition, p. 3703–3714. Copyright Elsevier 2002.
438 CHAPTER 10 Trauma to the urinary tract
Figure 10.9 Transureteroureterostomy. This figure was published in Walsh PC, et al. Campbell’s Urology, 8th edition, p. 3703–3714. Copyright Elsevier 2002.
This page intentionally left blank